CLINICAL TRIALS PROFILE FOR DUONEB

All Clinical Trials for DUONEB

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01933984 ↗	Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients	Completed	Shin-hwar Wu	N/A	2013-08-01	This study evaluates whether individualized dosing schedule of inhaled bronchodilator is more effective than fixed dosing in reducing airway resistance of intubated COPD patients.
NCT02872597 ↗	Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus	Completed	University Hospitals Cleveland Medical Center	Phase 1	2016-09-05	This study is a Phase I study to investigate the addition of inhaled Ipratropium bromide to standard therapy in the treatment of severe asthma attacks in children admitted to the Pediatric Intensive Care Unit. Half of the subjects will receive inhaled Ipratropium, and half will receive an inhaled placebo.

Clinical Trial Conditions for DUONEB

Condition Name

Condition Name for DUONEB
Intervention	Trials
Chronic Obstructive Pulmonary Disease	1
Status Asthmaticus	1

Condition MeSH

Condition MeSH for DUONEB
Intervention	Trials
Status Asthmaticus	1
Pulmonary Disease, Chronic Obstructive	1
Lung Diseases, Obstructive	1
Lung Diseases	1

Clinical Trial Locations for DUONEB

Trials by Country

Trials by Country for DUONEB
Location	Trials
China	1
United States	1

Trials by US State

Trials by US State for DUONEB
Location	Trials
Ohio	1

Clinical Trial Progress for DUONEB

Clinical Trial Phase

Clinical Trial Phase for DUONEB
Clinical Trial Phase	Trials
Phase 1	1
N/A	1

Clinical Trial Status

Clinical Trial Status for DUONEB
Clinical Trial Phase	Trials
Completed	2

Clinical Trial Sponsors for DUONEB

Sponsor Name

Sponsor Name for DUONEB
Sponsor	Trials
University Hospitals Cleveland Medical Center	1
Shin-hwar Wu	1

Sponsor Type

Sponsor Type for DUONEB
Sponsor	Trials
Other	2